The first organometallic antioestrogens and their antiproliferative effects

Comptes Rendus de l'Academie des Sciences - Series IIc: Chemistry

Volumn 3, Issue 2, 2000, Pages 89-93

  Jaouen, Gérard ^a   Top, Siden ^a   Vessières, Anne ^a   Leclercq, Guy ^b   Quivy, Jacques ^b   Jin, Lu ^b   Croisy, Alain ^c  

^a PSL RESEARCH UNIVERSITY   (France)

^b JULES BORDET INSTITUTE   (Belgium)

^c INSTITUT CURIE   (France)

Author keywords

Antitumoraux; Complexes des alc nes; Ferroc ne; M talloc nes; R cepteurs; St ro des

Indexed keywords

EID: 0042139572     PISSN: 13871609     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1387-1609(00)00118-3     Document Type: Article

References (28)

1. a) MacGregor J.I., Jordan V.C., Pharmacol. Rev. 50 (1998) 151.
2. b) Legros N., Jin L., Leclercq G., Cancer, Chemother. Pharmacol. 39 (1997) 380.
3. c) Nayfield S.G., Karp J.E., Ford L.G., Dorr F.A., Kramer B.S., J. Natl. Cancer Int. 23 (1991) 1450.
4. Magarian R.A., Overacre L.B., Singh S., Meyer K.L. Curr. Med. Chem. 1:1994;61.
5. a) Grese T.A., Cho S., Finley D.R. et al., J. Med. Chem. 40 (1997) 146.
6. b) Levenson A.S., Jordan V.C., Canc. Res. 58 (1998) 1872.
7. c) Jiang S.Y., Parker C.J., Jordan V.C., Breast Cancer Res. Treat. 26 (1993) 139.
8. d) Parker M.G., Breast Cancer Res. Treat. 26 (1993) 131.
9. a) Top S., Tang J., Vessières A., Carrez D., Provot C., Jaouen G., J.C.S. Chem. Commun. (1996) 955.
10. b) Top S., Dauer B., Vaissermann J., Jaouen G., J. Organomet. Chem. 541 (1997) 355.
11. a) Top S., Tang J., Vessières A., Carrez D., Provot C., Jaouen G., J.C.S. Chem. Commun. (1996) 955; J.C.S. Chem. Commun. (1996) 955; 997) S1-71.
12. a) Top S., Tang J., Vessières A., Carrez D., Provot C., Jaouen G., J.C.S. Chem. Commun. (1996) 955; J.C.S. Chem. Commun. (1996) 955; 997) S1-71.
13. a) Top S., Tang J., Vessières A., Carrez D., Provot C., Jaouen G., J.C.S. Chem. Commun. (1996) 955; J.C.S. Chem. Commun. (1996) 955; 997) S1-71; b) Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J-Å., Kushner P.J., Scanlan T.S., Science 277 (1997) 1508.
14. a) Köpf-Maier P., Eur. J. Clin. Pharmacol. 47 (1994) 1.
15. a) Köpf-Maier P., Eur. J. Clin. Pharmacol. 47 (1994) 1; b) Houlton A., Roberts R.M.G., Silver J., J. Organomet. Chem. 418 (1991) 107.
16. Top S. et al., manuscript in preparation.
17. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.-Å., Carlquist M. Nature. 389:1997;753.
18. Jin L., Legros N., Leclercq G., Hardcastle I.R., Jarman M. Cancer Chemother. Pharmacol. 41:1998;339.
19. Hardcastle I.R., Rowlands M.G., Grimshaw R.M., Houghton J., Jarman M. J. Med. Chem. 39:1996;999.
20. Vessières A., Top S., Ismail A.A., Butler I.S., Loüer M., Jaouen G. Biochemistry. 27:1988;6659.
21. Top S., El Hafa H., Vessières A., Quivy J., Vaissermann J., Hughes D.W., McGlinchey M.J., Mornon J.P., Thoreau E., Jaouen G. J. Am. Chem. Soc. 117:1995;8372.
22. Leclercq G., Devleeschouwer N., Heuson J.C. J. Steroid Biochem. 19:1983;75.
23. Faye J.C., Jozan S., Redeuilh G., Baulieu E.E., Bayard F. Proc. Natl. Acad. Sci. USA. 80:1983;3158.
24. Van Roy F., Mareel M., Vleminckx K., Beyaert R., Fiers W., Devleeschouwer N., Muquardt C., Legros N., Bracke M., Leclercq G. Int. J. Cancer. 46:1990;522.
25. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J-Å. Proc. Natl. Acad. Sci. USA. 93:1996;5925.
26. Vladusic E.A., Hornby A.E., Guerra-Vladusic F.K., Lupu R. Canc. Res. 58:1998;210.
27. Colletta A.A., Benson J.R., Baum M. Breast Cancer Res. Treat. 31:1994;5.
28. Jordan V.C., Allen K.E. Eur. J. Cancer. 16:1980;239.